Saltar al contenido
Merck

GF34540185

Antimony

foil, light tested, 50x50mm, thickness 0.05mm, permanent polyester support, 95+%

Sinónimos:

Antimony, SB000190

Iniciar sesión para ver los precios por organización y contrato.

Seleccione un Tamaño

Cambiar Vistas

Acerca de este artículo

Fórmula empírica (notación de Hill):
Sb
Número CAS:
Peso molecular:
121.76
NACRES:
NA.23
PubChem Substance ID:
UNSPSC Code:
12141704
MDL number:
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarle


assay

95%

form

foil

manufacturer/tradename

Goodfellow 345-401-85

resistance

41.7 μΩ-cm

size × thickness

50x50 mm × 0.05 mm

bp

1635 °C (lit.)

density

6.69 g/mL at 25 °C (lit.)

SMILES string

[Sb]

InChI

1S/Sb

InChI key

WATWJIUSRGPENY-UHFFFAOYSA-N

General description

For updated SDS information please visit www.goodfellow.com.

Legal Information

Product of Goodfellow


Still not finding the right product?

Explore all of our products under


Clase de almacenamiento

13 - Non Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable



Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documentos section.

Si necesita más asistencia, póngase en contacto con Atención al cliente

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos



Edward R T Tiekink
Critical reviews in oncology/hematology, 42(3), 217-224 (2002-06-07)
The main group elements antimony and bismuth are used clinically, primarily for the treatment of Leishmaniasis (antimony) and ulcers (bismuth). Despite their medicinal efficacy, the exploration of the anti-cancer potential of antimony and bismuth compounds is not as well developed
Khatima Aït-Oudhia et al.
Parasitology research, 109(5), 1225-1232 (2011-07-30)
Leishmania is the causative agent of various forms of leishmaniasis, a significant cause of morbidity and mortality. The clinical manifestations of the disease range from self-healing cutaneous and mucocutaneous skin ulcers to a fatal visceral form named visceral leishmaniasis or
Ricardo Khouri et al.
The Journal of infectious diseases, 210(2), 306-310 (2014-02-11)
We show that increased plasma superoxide dismutase 1 (SOD1) levels are statistically significant predictors of the failure of pentavalent antimony treatment for cutaneous leishmaniasis caused by Leishmania braziliensis. In Leishmania amazonensis-infected patients, host SOD1 levels can be used to discriminate